
Syndax Pharmaceuticals, Inc.
USD21.78
+0.47 (+2.21%)
CEO
Michael A. Metzger
IPO Date
2016-03-02
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$21.20
Prev. Close
$21.31
Day Low
$20.86
Day High
$22.05
52W Low
$8.59
52W High
$25.59
Market Cap
$1.93B
Volume
4.23M
| 1 May 2026 |
| Barclays |
| Overweight |
| Overweight |
| maintain |
| 1 Apr 2026 | Goldman Sachs | Buy | Buy | maintain |
| 31 Mar 2026 | Mizuho | Outperform | Outperform | maintain |
| 9 Mar 2026 | JP Morgan | Overweight | Overweight | maintain |
| 2 Mar 2026 | Citigroup | Buy | Buy | maintain |
| 27 Jan 2026 | Mizuho | Outperform | Outperform | maintain |
| 9 Dec 2025 | BTIG | Buy | Buy | maintain |